Provider review
Amble review
The "$99/mo" homepage banner is a promotional rate — starting dose runs $179/mo standard
The homepage banner says "Plans starting at $99 per month"; the standing starting-dose price is $179. Our last check of the intake flow found tirzepatide running well above its advertised figure with a fee that surfaced only at checkout — worth walking the funnel yourself before you commit.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Amble prices compounded semaglutide starting at $179/month standard, with a "Plans starting at $99 per month" banner prominently displayed on the homepage — a promotional figure well below the standing starting-dose rate. A deeper inspection of the site's purchase flow at our last check, not re-verified since, found Amble's tirzepatide pricing running substantially above its advertised figure, with a fee surfacing only at checkout that isn't disclosed on the marketing pages. It also offers NAD+ and sermorelin alongside GLP-1, and is available in all 50 states.
Amble is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You've confirmed the actual checkout price directly before assuming the $99/mo banner applies to you
- You want NAD+ and sermorelin available alongside GLP-1 from one platform
- You want all-50-state availability
Look elsewhere if
- You'd take the "$99/mo" homepage banner as the standing rate — it's promotional; starting dose is $179/mo standard
- You want tirzepatide pricing and any checkout fees fully disclosed before you reach the purchase flow
- You want a specific compounding pharmacy named
What it actually costs
What they advertise
"Plans starting at $99 per month" homepage banner, per joinamble.com —; standing starting-dose price is $179/mo.
What you actually pay, month to month
The $99/mo figure is a promotional banner rate; the standard starting-dose price for compounded semaglutide is $179/month.
The commitment trap
The homepage prominently displays "$99 per month" while the standing starting-dose rate is $179/month — a real gap between the banner and the standard price.
Money you will meet later
- Unconfirmed since our last check, tirzepatide pricing and an undisclosed checkout fee have been found to run above the advertised figures
Checked live on Amble's own site at https://joinamble.com/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Amble bundles in, and what it does not.
Clinician consult
Not published.
Bloodwork / labs
Not published.
Follow-ups and dose changes
No cadence published.
Human support
Not itemized.
Injection supplies
Not itemized.
Shipping
No terms published.
Pharmacy, labs and oversight
The pharmacy
Not named.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
All 50 states, per the homepage.
The honest cons
The part they would rather you skipped
The homepage's largest-type banner reads "$99 per month," a figure well below the standard $179/month starting-dose price — and at our last check not reconfirmed, the actual checkout flow has been found to add pricing and fees not disclosed on the marketing pages a reader sees first.
- Homepage banner ("$99/mo") is a promotional rate, not the standard starting-dose price ($179/mo)
- Unconfirmed since our last check: tirzepatide pricing and an undisclosed checkout fee running above the advertised figures
- Compounding pharmacy not named
- Limited public information on program details beyond pricing
None of this is unique to Amble — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. Amble is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Amble's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Amble's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.